- Home
- MPV vs TIL Comparison
MPV vs TIL Comparison
Compare MPV & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPV
- TIL
- Stock Information
- Founded
- MPV 1988
- TIL 2018
- Country
- MPV United States
- TIL United States
- Employees
- MPV N/A
- TIL N/A
- Industry
- MPV Finance Companies
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- MPV Finance
- TIL Health Care
- Exchange
- MPV Nasdaq
- TIL Nasdaq
- Market Cap
- MPV 183.8M
- TIL 171.7M
- IPO Year
- MPV N/A
- TIL 2021
- Fundamental
- Price
- MPV $17.61
- TIL $26.95
- Analyst Decision
- MPV
- TIL Buy
- Analyst Count
- MPV 0
- TIL 5
- Target Price
- MPV N/A
- TIL $119.00
- AVG Volume (30 Days)
- MPV 25.2K
- TIL 316.4K
- Earning Date
- MPV 01-01-0001
- TIL 05-13-2025
- Dividend Yield
- MPV 8.71%
- TIL N/A
- EPS Growth
- MPV N/A
- TIL N/A
- EPS
- MPV 1.71
- TIL N/A
- Revenue
- MPV N/A
- TIL N/A
- Revenue This Year
- MPV N/A
- TIL N/A
- Revenue Next Year
- MPV N/A
- TIL N/A
- P/E Ratio
- MPV $9.35
- TIL N/A
- Revenue Growth
- MPV N/A
- TIL N/A
- 52 Week Low
- MPV $11.18
- TIL $9.62
- 52 Week High
- MPV $16.42
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- MPV 58.01
- TIL 65.08
- Support Level
- MPV $17.05
- TIL $12.60
- Resistance Level
- MPV $18.13
- TIL $35.28
- Average True Range (ATR)
- MPV 0.29
- TIL 3.84
- MACD
- MPV 0.04
- TIL 1.60
- Stochastic Oscillator
- MPV 55.17
- TIL 63.27
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.